Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Follow-Up Questions
Quel est le ratio P/E de Bruker Corp (BRKRP) ?
Le ratio P/E de Bruker Corp est de 48.628
Qui est le CEO de Bruker Corp ?
Dr. Frank Laukien est le Chairman of the Board de Bruker Corp, il a rejoint l'entreprise depuis 1991.
Quelle est la performance du prix de l'action BRKRP ?
Le prix actuel de BRKRP est de $300.23, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Bruker Corp ?
Bruker Corp appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quelle est la capitalisation boursière de Bruker Corp ?
La capitalisation boursière actuelle de Bruker Corp est de $45.5B
Est-ce que Bruker Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 16 analystes ont établi des notations d'analystes pour Bruker Corp, y compris 6 achat fort, 6 achat, 8 maintien, 1 vente et 6 vente forte
